1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)High-risk Human Papillomavirus Infection; Human Papilloma Virus (HPV)RecruitingPhase 22026-08-25NCT07601074